Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Epperson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
American Family Physician|April 30, 1999
Postpartum major depression: detection and treatmentC N Epperson
Psychosomatic Medicine|October 8, 1999
Gonadal steroids in the treatment of mood disordersC N Epperson, K L Wisner, B Yamamoto
The New England Journal of Medicine|April 17, 1997
Sertraline and breast-feedingC N Epperson, G M Anderson, C J McDougle
Biological Psychiatry|September 15, 1996
Intranasal oxytocin in obsessive-compulsive disorderC N Epperson, C J McDougle, L H Price
Biological Psychiatry|September 15, 1996
Intranasal oxytocin in trichotillomaniaC N Epperson, C J McDougle, L H Price
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1996
Obsessive-compulsive symptoms with-neurolepticsC J McDougle, C N Epperson, L H Price
The American Journal of Psychiatry|September 12, 1998
Olanzapine augmentation of fluoxetine in the treatment of trichotillomaniaM N Potenza, S Wasylink, C N Epperson, et al.
Molecular Psychiatry|July 22, 1998
Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorderC J McDougle, C N Epperson, L H Price, et al.
The Journal of Clinical Psychiatry|September 15, 1999
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case seriesE L Weiss, M N Potenza, C J McDougle, et al.
Drug Safety|August 1, 1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorderL L Carpenter, C J McDougle, C N Epperson, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
American Family Physician|April 30, 1999
Postpartum major depression: detection and treatmentC N Epperson
Psychosomatic Medicine|October 8, 1999
Gonadal steroids in the treatment of mood disordersC N Epperson, K L Wisner, B Yamamoto
The New England Journal of Medicine|April 17, 1997
Sertraline and breast-feedingC N Epperson, G M Anderson, C J McDougle
Biological Psychiatry|September 15, 1996
Intranasal oxytocin in obsessive-compulsive disorderC N Epperson, C J McDougle, L H Price
Biological Psychiatry|September 15, 1996
Intranasal oxytocin in trichotillomaniaC N Epperson, C J McDougle, L H Price
Journal of the American Academy of Child and Adolescent Psychiatry|July 1, 1996
Obsessive-compulsive symptoms with-neurolepticsC J McDougle, C N Epperson, L H Price
The American Journal of Psychiatry|September 12, 1998
Olanzapine augmentation of fluoxetine in the treatment of trichotillomaniaM N Potenza, S Wasylink, C N Epperson, et al.
Molecular Psychiatry|July 22, 1998
Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorderC J McDougle, C N Epperson, L H Price, et al.
The Journal of Clinical Psychiatry|September 15, 1999
Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case seriesE L Weiss, M N Potenza, C J McDougle, et al.
Drug Safety|August 1, 1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorderL L Carpenter, C J McDougle, C N Epperson, et al.
Pageof 2